
A drug currently used for the skin condition psoriasis could help treat diabetes in children and young people without the need for insulin, a study has found.
Researchers trialled the use of a drug named Ustekinumab, an immunotherapy, in 72 children between the ages of 12 and 18 with recent-onset type-1 diabetes.